In the last 12 months, insiders at INCYTE CORP ($INCY) filed 389 transactions with the SEC: 0 open-market purchases totaling $0 and 67 sales totaling $48,933,333. Net insider sentiment: net selling.
INCYTE CORP operates in the Services-commercial physical & biological research industry (Industrial Applications and Services sector).
Most Active Insiders
- BAKER BROS. ADVISORS LP (Not found) — 34 transactions totaling $329,021,280
- Hoppenot Herve (Director) — 2 transactions totaling $20,048,668
- Stein Steven H (EVP & Chief Medical Officer) — 34 transactions totaling $13,802,728
- Morrissey Michael James (EVP, Head of Tech. Operations) — 18 transactions totaling $6,615,177
- Flannelly Barry P (EVP & General Manager US) — 30 transactions totaling $6,380,921
View all SEC Filings for INCYTE CORP (INCY).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Clancy Paul J | Director | A | Common Stock | 265 | $94.12 | 23,741.0000 | 200,700,000 | 1.13% | 0.00% |
| March 31, 2026 | HARRIGAN EDMUND | Director | A | Common Stock | 269 | $94.12 | 21,122.0000 | 200,700,000 | 1.29% | 0.00% |
| March 31, 2026 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 421 | $0.00 | 28,782,091.0000 | 200,700,000 | 0.00% | 0.00% |
| March 31, 2026 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 421 | $0.00 | 3,411,412.0000 | 200,700,000 | 0.01% | 0.00% |
| March 25, 2026 | Trotta Matteo | EVP, GM, Dermatology US | F | Common Stock | 537 | $92.23 | 14,882.0000 | 200,700,000 | 3.48% | 0.00% |
| March 17, 2026 | CAGNONI PABLO J | President, R&D | M | Common Stock | 7166 | $61.18 | 241,966.0000 | 200,700,000 | 3.05% | 0.00% |
| March 17, 2026 | CAGNONI PABLO J | President, R&D | M | Employee Stock Option (right to buy) | 11501 | $0.00 | 32,910.0000 | 200,700,000 | 25.90% | 0.01% |
| March 17, 2026 | CAGNONI PABLO J | President, R&D | M | Employee Stock Option (right to buy) | 7166 | $0.00 | 9,102.0000 | 200,700,000 | 44.05% | 0.00% |
| March 17, 2026 | CAGNONI PABLO J | President, R&D | S | Common Stock | 18667 | $94.24 | 234,800.0000 | 200,700,000 | 7.36% | 0.01% |
| March 17, 2026 | CAGNONI PABLO J | President, R&D | M | Common Stock | 11501 | $64.25 | 253,467.0000 | 200,700,000 | 4.75% | 0.01% |
| Feb. 19, 2026 | CAGNONI PABLO J | President, R&D | M | Common Stock | 5575 | $61.18 | 253,468.0000 | 200,700,000 | 2.25% | 0.00% |
| Feb. 19, 2026 | CAGNONI PABLO J | President, R&D | M | Employee Stock Option (right to buy) | 13093 | $0.00 | 7,182.0000 | 200,700,000 | 64.58% | 0.01% |
| Feb. 19, 2026 | CAGNONI PABLO J | President, R&D | M | Employee Stock Option (right to buy) | 5575 | $0.00 | 16,268.0000 | 200,700,000 | 25.52% | 0.00% |
| Feb. 19, 2026 | CAGNONI PABLO J | President, R&D | M | Common Stock | 13093 | $61.76 | 247,893.0000 | 200,700,000 | 5.58% | 0.01% |
| Feb. 19, 2026 | CAGNONI PABLO J | President, R&D | S | Common Stock | 18668 | $100.91 | 234,800.0000 | 200,700,000 | 7.37% | 0.01% |
| Feb. 2, 2026 | Morrissey Michael James | EVP, Head of Tech. Operations | F | Common Stock | 185 | $102.67 | 34,065.0000 | 200,700,000 | 0.54% | 0.00% |
| Feb. 2, 2026 | Heeson Lee | EVP, Head of Incyte Intl | F | Common Stock | 111 | $102.67 | 38,041.0000 | 200,700,000 | 0.29% | 0.00% |
| Jan. 20, 2026 | Morrissey Michael James | EVP, Head of Tech. Operations | F | Common Stock | 429 | $102.62 | 34,250.0000 | 200,700,000 | 1.24% | 0.00% |
| Jan. 16, 2026 | Heeson Lee | EVP, Head of Incyte Intl | A | Common Stock | 8911 | $0.00 | 38,152.0000 | 200,700,000 | 30.47% | 0.00% |
| Jan. 16, 2026 | Stein Steven H | EVP & Chief Medical Officer | A | Employee Stock Option (right to buy) | 19932 | $0.00 | 19,932.0000 | 200,700,000 | 9999.99% | 0.01% |
| Jan. 16, 2026 | Issa Mohamed Khairie | EVP, Head of US Oncology | A | Employee Stock Option (right to buy) | 14237 | $0.00 | 14,237.0000 | 200,700,000 | 9999.99% | 0.01% |
| Jan. 16, 2026 | Trotta Matteo | EVP, GM, Dermatology US | A | Employee Stock Option (right to buy) | 8542 | $0.00 | 8,542.0000 | 200,700,000 | 9999.99% | 0.00% |
| Jan. 16, 2026 | Tray Thomas | Principal Accounting Officer | A | Employee Stock Option (right to buy) | 2425 | $0.00 | 2,425.0000 | 200,700,000 | 9999.99% | 0.00% |
| Jan. 16, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | A | Employee Stock Option (right to buy) | 4218 | $0.00 | 4,218.0000 | 200,700,000 | 9999.99% | 0.00% |
| Jan. 16, 2026 | Morrissey Michael James | EVP, Head of Tech. Operations | A | Common Stock | 7426 | $0.00 | 34,679.0000 | 200,700,000 | 27.25% | 0.00% |
| Jan. 16, 2026 | CAGNONI PABLO J | President, R&D | A | Employee Stock Option (right to buy) | 28475 | $0.00 | 28,475.0000 | 200,700,000 | 9999.99% | 0.01% |
| Jan. 7, 2026 | Issa Mohamed Khairie | EVP, Head of US Oncology | S | Common Stock | 10856 | $109.07 | 66,132.0000 | 200,700,000 | 14.10% | 0.01% |
| Jan. 6, 2026 | Issa Mohamed Khairie | EVP, Head of US Oncology | F | Common Stock | 8264 | $106.66 | 76,988.0000 | 200,700,000 | 9.69% | 0.00% |
| Jan. 5, 2026 | Stein Steven H | EVP & Chief Medical Officer | S | Common Stock | 15634 | $101.70 | 34,203.0000 | 200,700,000 | 31.37% | 0.01% |
| Dec. 31, 2025 | Stein Steven H | EVP & Chief Medical Officer | F | Common Stock | 13292 | $98.77 | 49,837.0000 | 201,429,000 | 21.06% | 0.01% |
| Dec. 31, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 328 | $0.00 | 28,781,670.0000 | 201,429,000 | 0.00% | 0.00% |
| Dec. 31, 2025 | Morrissey Michael James | EVP, Head of Tech. Operations | F | Common Stock | 254 | $98.77 | 27,253.0000 | 201,429,000 | 0.92% | 0.00% |
| Dec. 31, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 328 | $0.00 | 3,410,991.0000 | 201,429,000 | 0.01% | 0.00% |
| Dec. 31, 2025 | Clancy Paul J | Director | A | Common Stock | 241 | $98.77 | 23,476.0000 | 201,429,000 | 1.04% | 0.00% |
| Dec. 31, 2025 | HARRIGAN EDMUND | Director | A | Common Stock | 245 | $98.77 | 20,853.0000 | 201,429,000 | 1.19% | 0.00% |
| Dec. 18, 2025 | Tray Thomas | Principal Accounting Officer | S | Common Stock | 600 | $98.25 | 22,973.0000 | 201,429,000 | 2.55% | 0.00% |
| Dec. 19, 2025 | Tray Thomas | Principal Accounting Officer | M | Common Stock | 1044 | $95.76 | 24,017.0000 | 201,429,000 | 4.54% | 0.00% |
| Dec. 19, 2025 | Tray Thomas | Principal Accounting Officer | M | Common Stock | 1730 | $95.76 | 25,747.0000 | 201,429,000 | 7.20% | 0.00% |
| Dec. 19, 2025 | Tray Thomas | Principal Accounting Officer | S | Common Stock | 2774 | $100.00 | 22,973.0000 | 201,429,000 | 10.77% | 0.00% |
| Dec. 19, 2025 | Tray Thomas | Principal Accounting Officer | M | Incentive Stock Option (right to buy) | 1044 | $0.00 | 0.0000 | 201,429,000 | 100.00% | 0.00% |
| Dec. 19, 2025 | Tray Thomas | Principal Accounting Officer | M | Non-Qualified Stock Option (right to buy) | 1730 | $0.00 | 0.0000 | 201,429,000 | 100.00% | 0.00% |
| Dec. 17, 2025 | Morrissey Michael James | EVP, Head of Tech. Operations | S | Common Stock | 4323 | $97.26 | 27,507.0000 | 201,429,000 | 13.58% | 0.00% |
| Dec. 16, 2025 | Morrissey Michael James | EVP, Head of Tech. Operations | S | Common Stock | 833 | $97.42 | 85,005.0000 | 201,429,000 | 0.97% | 0.00% |
| Dec. 16, 2025 | Morrissey Michael James | EVP, Head of Tech. Operations | S | Common Stock | 53175 | $97.29 | 31,830.0000 | 201,429,000 | 62.56% | 0.03% |
| Dec. 11, 2025 | Mayes Patrick A | EVP & Chief Scientific Officer | S | Common Stock | 255 | $94.94 | 60,011.0000 | 201,429,000 | 0.42% | 0.00% |
| Dec. 10, 2025 | Mayes Patrick A | EVP & Chief Scientific Officer | S | Common Stock | 5553 | $95.58 | 60,266.0000 | 201,429,000 | 8.44% | 0.00% |
| Dec. 8, 2025 | Hoppenot Herve | Director | F | Common Stock | 2843 | $96.70 | 326,803.0000 | 201,429,000 | 0.86% | 0.00% |
| Dec. 2, 2025 | Stein Steven H | EVP & Chief Medical Officer | S | Common Stock | 20105 | $102.51 | 63,129.0000 | 201,429,000 | 24.15% | 0.01% |
| Dec. 1, 2025 | Morrissey Michael James | EVP, Head of Tech. Operations | F | Common Stock | 326 | $102.04 | 85,838.0000 | 201,429,000 | 0.38% | 0.00% |
| Dec. 1, 2025 | Hoffman Richard A. | EVP & General Counsel | A | Common Stock | 9466 | $0.00 | 9,466.0000 | 201,429,000 | 9999.99% | 0.00% |
| Dec. 1, 2025 | Hoffman Richard A. | EVP & General Counsel | A | Performance Shares | 23665 | $0.00 | 23,665.0000 | 201,429,000 | 9999.99% | 0.01% |
| Dec. 1, 2025 | Hoffman Richard A. | EVP & General Counsel | A | Employee Stock Option (right to buy) | 43301 | $0.00 | 43,301.0000 | 201,429,000 | 9999.99% | 0.02% |
| Dec. 1, 2025 | Stein Steven H | EVP & Chief Medical Officer | S | Common Stock | 2559 | $102.96 | 100,327.0000 | 201,429,000 | 2.49% | 0.00% |
| Dec. 1, 2025 | Stein Steven H | EVP & Chief Medical Officer | F | Common Stock | 17093 | $102.04 | 83,234.0000 | 201,429,000 | 17.04% | 0.01% |
| Nov. 24, 2025 | Tray Thomas | Principal Accounting Officer | S | Common Stock | 600 | $103.00 | 23,573.0000 | 201,429,000 | 2.48% | 0.00% |
| Nov. 21, 2025 | Tray Thomas | Principal Accounting Officer | S | Common Stock | 169 | $102.00 | 24,173.0000 | 201,429,000 | 0.69% | 0.00% |
| Nov. 17, 2025 | Denton Sheila A. | EVP & General Counsel | M | Employee Stock Option (right to buy) | 278 | $0.00 | 8,883.0000 | 201,429,000 | 3.03% | 0.00% |
| Nov. 17, 2025 | Denton Sheila A. | EVP & General Counsel | S | Common Stock | 278 | $104.36 | 26,569.0000 | 201,429,000 | 1.04% | 0.00% |
| Nov. 17, 2025 | Denton Sheila A. | EVP & General Counsel | M | Common Stock | 278 | $64.25 | 26,847.0000 | 201,429,000 | 1.05% | 0.00% |
| Nov. 10, 2025 | Hoppenot Herve | Director | S | Common Stock | 187500 | $105.46 | 329,646.0000 | 201,429,000 | 36.26% | 0.09% |
| Nov. 5, 2025 | Stein Steven H | EVP & Chief Medical Officer | S | Common Stock | 5233 | $102.20 | 102,886.0000 | 201,429,000 | 4.84% | 0.00% |
| Nov. 5, 2025 | Stein Steven H | EVP & Chief Medical Officer | M | Common Stock | 1044 | $95.76 | 108,119.0000 | 201,429,000 | 0.98% | 0.00% |
| Nov. 5, 2025 | Stein Steven H | EVP & Chief Medical Officer | M | Common Stock | 2995 | $95.76 | 107,075.0000 | 201,429,000 | 2.88% | 0.00% |
| Nov. 5, 2025 | Stein Steven H | EVP & Chief Medical Officer | M | Incentive Stock Option (right to buy) | 1044 | $0.00 | 0.0000 | 201,429,000 | 100.00% | 0.00% |
| Nov. 5, 2025 | Stein Steven H | EVP & Chief Medical Officer | M | Common Stock | 1194 | $83.83 | 104,080.0000 | 201,429,000 | 1.16% | 0.00% |
| Nov. 5, 2025 | Stein Steven H | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 2995 | $0.00 | 0.0000 | 201,429,000 | 100.00% | 0.00% |
| Nov. 5, 2025 | Stein Steven H | EVP & Chief Medical Officer | M | Non-Qualified Stock Option (right to buy) | 1194 | $0.00 | 0.0000 | 201,429,000 | 100.00% | 0.00% |
| Nov. 4, 2025 | Denton Sheila A. | EVP & General Counsel | M | Employee Stock Option (right to buy) | 598 | $0.00 | 13,765.0000 | 201,429,000 | 4.16% | 0.00% |
| Nov. 4, 2025 | Denton Sheila A. | EVP & General Counsel | M | Common Stock | 598 | $58.06 | 27,167.0000 | 201,429,000 | 2.25% | 0.00% |
| Nov. 4, 2025 | Denton Sheila A. | EVP & General Counsel | S | Common Stock | 598 | $101.36 | 26,569.0000 | 201,429,000 | 2.20% | 0.00% |
| Nov. 3, 2025 | Heeson Lee | EVP, Head of Incyte Intl | S | Common Stock | 3074 | $94.02 | 29,241.0000 | 201,429,000 | 9.51% | 0.00% |
| Oct. 15, 2025 | Denton Sheila A. | EVP & General Counsel | S | Common Stock | 277 | $85.13 | 26,569.0000 | 201,429,000 | 1.03% | 0.00% |
| Oct. 15, 2025 | Denton Sheila A. | EVP & General Counsel | M | Common Stock | 277 | $64.25 | 26,846.0000 | 201,429,000 | 1.04% | 0.00% |
| Oct. 15, 2025 | Denton Sheila A. | EVP & General Counsel | M | Employee Stock Option (right to buy) | 277 | $0.00 | 9,161.0000 | 201,429,000 | 2.93% | 0.00% |
| Oct. 2, 2025 | Denton Sheila A. | EVP & General Counsel | F | Common Stock | 3130 | $86.28 | 30,070.0000 | 201,429,000 | 9.43% | 0.00% |
| Oct. 2, 2025 | Denton Sheila A. | EVP & General Counsel | M | Employee Stock Option (right to buy) | 599 | $0.00 | 14,363.0000 | 201,429,000 | 4.00% | 0.00% |
| Oct. 2, 2025 | Denton Sheila A. | EVP & General Counsel | S | Common Stock | 599 | $87.65 | 33,200.0000 | 201,429,000 | 1.77% | 0.00% |
| Oct. 3, 2025 | Denton Sheila A. | EVP & General Counsel | S | Common Stock | 3501 | $85.54 | 26,569.0000 | 201,429,000 | 11.64% | 0.00% |
| Oct. 2, 2025 | Denton Sheila A. | EVP & General Counsel | M | Common Stock | 599 | $58.06 | 33,799.0000 | 201,429,000 | 1.80% | 0.00% |
| Oct. 1, 2025 | Mayes Patrick A | EVP & Chief Scientific Officer | F | Common Stock | 1569 | $86.70 | 65,819.0000 | 201,429,000 | 2.33% | 0.00% |
| Oct. 1, 2025 | Heeson Lee | EVP, Head of Incyte Intl | F | Common Stock | 463 | $86.70 | 32,315.0000 | 201,429,000 | 1.41% | 0.00% |
| Sept. 30, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 388 | $0.00 | 28,781,342.0000 | 210,530,000 | 0.00% | 0.00% |
| Sept. 30, 2025 | HARRIGAN EDMUND | Director | A | Common Stock | 289 | $84.81 | 20,608.0000 | 210,530,000 | 1.42% | 0.00% |
| Sept. 30, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 388 | $0.00 | 3,410,663.0000 | 210,530,000 | 0.01% | 0.00% |
| Sept. 30, 2025 | Clancy Paul J | Director | A | Common Stock | 285 | $84.81 | 23,235.0000 | 210,530,000 | 1.24% | 0.00% |
| Sept. 22, 2025 | Gardner David H | EVP, Chief Strategy Officer | A | Performance Shares | 23573 | $0.00 | 23,573.0000 | 210,530,000 | 9999.99% | 0.01% |
| Sept. 22, 2025 | Gardner David H | EVP, Chief Strategy Officer | A | Common Stock | 9429 | $0.00 | 9,429.0000 | 210,530,000 | 9999.99% | 0.00% |
| Sept. 22, 2025 | Gardner David H | EVP, Chief Strategy Officer | A | Employee Stock Option (right to buy) | 42899 | $0.00 | 42,899.0000 | 210,530,000 | 9999.99% | 0.02% |
| Sept. 16, 2025 | Denton Sheila A. | EVP & General Counsel | M | Common Stock | 278 | $64.25 | 33,478.0000 | 210,530,000 | 0.84% | 0.00% |
| Sept. 16, 2025 | Denton Sheila A. | EVP & General Counsel | M | Employee Stock Option (right to buy) | 278 | $0.00 | 9,438.0000 | 210,530,000 | 2.86% | 0.00% |
| Sept. 16, 2025 | Denton Sheila A. | EVP & General Counsel | S | Common Stock | 278 | $83.15 | 33,200.0000 | 210,530,000 | 0.83% | 0.00% |
| Sept. 2, 2025 | Denton Sheila A. | EVP & General Counsel | M | Employee Stock Option (right to buy) | 598 | $0.00 | 14,962.0000 | 210,530,000 | 3.84% | 0.00% |
| Sept. 2, 2025 | Denton Sheila A. | EVP & General Counsel | M | Common Stock | 598 | $58.06 | 33,798.0000 | 210,530,000 | 1.80% | 0.00% |
| Sept. 2, 2025 | Denton Sheila A. | EVP & General Counsel | S | Common Stock | 598 | $84.97 | 33,200.0000 | 210,530,000 | 1.77% | 0.00% |
| Aug. 25, 2025 | Basi Ramitpal K | EVP, Human Resources | A | Employee Stock Option (right to buy) | 29230 | $0.00 | 29,230.0000 | 210,530,000 | 9999.99% | 0.01% |
| Aug. 25, 2025 | Basi Ramitpal K | EVP, Human Resources | A | Common Stock | 6506 | $0.00 | 6,506.0000 | 210,530,000 | 9999.99% | 0.00% |
| Aug. 25, 2025 | Basi Ramitpal K | EVP, Human Resources | A | Performance Shares | 16265 | $0.00 | 16,265.0000 | 210,530,000 | 9999.99% | 0.01% |
| Aug. 15, 2025 | Denton Sheila A. | EVP & General Counsel | M | Employee Stock Option (right to buy) | 277 | $0.00 | 9,716.0000 | 210,530,000 | 2.77% | 0.00% |
| Aug. 15, 2025 | Denton Sheila A. | EVP & General Counsel | S | Common Stock | 277 | $86.81 | 33,200.0000 | 210,530,000 | 0.83% | 0.00% |
| Aug. 15, 2025 | Denton Sheila A. | EVP & General Counsel | M | Common Stock | 277 | $64.25 | 33,477.0000 | 210,530,000 | 0.83% | 0.00% |
| Aug. 4, 2025 | Denton Sheila A. | EVP & General Counsel | M | Employee Stock Option (right to buy) | 598 | $0.00 | 15,560.0000 | 210,530,000 | 3.70% | 0.00% |
| Aug. 4, 2025 | Denton Sheila A. | EVP & General Counsel | M | Common Stock | 598 | $58.06 | 33,798.0000 | 210,530,000 | 1.80% | 0.00% |
| Aug. 4, 2025 | Denton Sheila A. | EVP & General Counsel | S | Common Stock | 598 | $75.77 | 33,200.0000 | 210,530,000 | 1.77% | 0.00% |
| July 21, 2025 | Stein Steven H | EVP & Chief Medical Officer | S | Common Stock | 3706 | $67.94 | 102,886.0000 | 210,530,000 | 3.48% | 0.00% |
| July 15, 2025 | Denton Sheila A. | EVP & General Counsel | A | Employee Stock Option (right to buy) | 18419 | $0.00 | 18,419.0000 | 210,530,000 | 9999.99% | 0.01% |
| July 15, 2025 | Denton Sheila A. | EVP & General Counsel | A | Performance Shares | 20461 | $0.00 | 20,461.0000 | 210,530,000 | 9999.99% | 0.01% |
| July 15, 2025 | Denton Sheila A. | EVP & General Counsel | M | Employee Stock Option (right to buy) | 3330 | $0.00 | 9,993.0000 | 210,530,000 | 24.99% | 0.00% |
| July 16, 2025 | Denton Sheila A. | EVP & General Counsel | S | Common Stock | 785 | $68.36 | 33,200.0000 | 210,530,000 | 2.31% | 0.00% |
| July 15, 2025 | Denton Sheila A. | EVP & General Counsel | A | Common Stock | 8184 | $0.00 | 33,985.0000 | 210,530,000 | 31.72% | 0.00% |
| July 15, 2025 | Denton Sheila A. | EVP & General Counsel | F | Common Stock | 703 | $68.25 | 25,801.0000 | 210,530,000 | 2.65% | 0.00% |
| July 15, 2025 | Trotta Matteo | EVP, GM, Dermatology US | F | Common Stock | 182 | $68.25 | 9,755.0000 | 210,530,000 | 1.83% | 0.00% |
| July 15, 2025 | Denton Sheila A. | EVP & General Counsel | M | Common Stock | 3330 | $64.25 | 29,834.0000 | 210,530,000 | 12.56% | 0.00% |
| July 16, 2025 | Iyengar Vijay K | EVP, GMAPPS | S | Common Stock | 983 | $68.36 | 40,540.0000 | 210,530,000 | 2.37% | 0.00% |
| July 16, 2025 | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 1340 | $68.36 | 35,149.0000 | 210,530,000 | 3.67% | 0.00% |
| July 15, 2025 | Morrissey Michael James | EVP, Head of Tech. Operations | A | Performance Shares | 10961 | $0.00 | 10,961.0000 | 210,530,000 | 9999.99% | 0.01% |
| July 15, 2025 | Heeson Lee | EVP, Head of Incyte Intl | A | Performance Shares | 6577 | $0.00 | 6,577.0000 | 210,530,000 | 9999.99% | 0.00% |
| July 15, 2025 | Trotta Matteo | EVP, GM, Dermatology US | A | Employee Stock Option (right to buy) | 11841 | $0.00 | 11,841.0000 | 210,530,000 | 9999.99% | 0.01% |
| July 15, 2025 | Trotta Matteo | EVP, GM, Dermatology US | A | Performance Shares | 13154 | $0.00 | 13,154.0000 | 210,530,000 | 9999.99% | 0.01% |
| July 15, 2025 | Trotta Matteo | EVP, GM, Dermatology US | A | Common Stock | 5261 | $0.00 | 15,016.0000 | 210,530,000 | 53.93% | 0.00% |
| July 15, 2025 | Denton Sheila A. | EVP & General Counsel | S | Common Stock | 3330 | $69.86 | 26,504.0000 | 210,530,000 | 11.16% | 0.00% |
| July 15, 2025 | Issa Mohamed Khairie | EVP, Head of US Oncology | A | Employee Stock Option (right to buy) | 19735 | $0.00 | 19,735.0000 | 210,530,000 | 9999.99% | 0.01% |
| July 15, 2025 | Issa Mohamed Khairie | EVP, Head of US Oncology | A | Performance Shares | 21923 | $0.00 | 21,923.0000 | 210,530,000 | 9999.99% | 0.01% |
| July 15, 2025 | Issa Mohamed Khairie | EVP, Head of US Oncology | A | Common Stock | 8769 | $0.00 | 85,252.0000 | 210,530,000 | 11.47% | 0.00% |
| July 15, 2025 | Tray Thomas | Principal Accounting Officer | F | Common Stock | 583 | $68.25 | 19,831.0000 | 210,530,000 | 2.86% | 0.00% |
| July 14, 2025 | CAGNONI PABLO J | President, R&D | F | Common Stock | 1280 | $69.98 | 219,890.0000 | 210,530,000 | 0.58% | 0.00% |
| July 15, 2025 | CAGNONI PABLO J | President, R&D | F | Common Stock | 2628 | $68.25 | 217,262.0000 | 210,530,000 | 1.20% | 0.00% |
| July 15, 2025 | CAGNONI PABLO J | President, R&D | A | Common Stock | 17538 | $0.00 | 234,800.0000 | 210,530,000 | 8.07% | 0.01% |
| July 15, 2025 | CAGNONI PABLO J | President, R&D | A | Performance Shares | 43846 | $0.00 | 43,846.0000 | 210,530,000 | 9999.99% | 0.02% |
| July 15, 2025 | CAGNONI PABLO J | President, R&D | A | Employee Stock Option (right to buy) | 39471 | $0.00 | 39,471.0000 | 210,530,000 | 9999.99% | 0.02% |
| July 14, 2025 | Stein Steven H | EVP & Chief Medical Officer | S | Common Stock | 14952 | $68.47 | 97,466.0000 | 210,530,000 | 13.30% | 0.01% |
| July 14, 2025 | Stein Steven H | EVP & Chief Medical Officer | F | Common Stock | 1555 | $69.98 | 95,911.0000 | 210,530,000 | 1.60% | 0.00% |
| July 15, 2025 | Stein Steven H | EVP & Chief Medical Officer | F | Common Stock | 1596 | $68.25 | 94,315.0000 | 210,530,000 | 1.66% | 0.00% |
| July 15, 2025 | Stein Steven H | EVP & Chief Medical Officer | A | Common Stock | 12277 | $0.00 | 106,592.0000 | 210,530,000 | 13.02% | 0.01% |
| July 15, 2025 | Stein Steven H | EVP & Chief Medical Officer | A | Performance Shares | 30692 | $0.00 | 30,692.0000 | 210,530,000 | 9999.99% | 0.01% |
| July 15, 2025 | Stein Steven H | EVP & Chief Medical Officer | A | Employee Stock Option (right to buy) | 27629 | $0.00 | 27,629.0000 | 210,530,000 | 9999.99% | 0.01% |
| July 14, 2025 | SWAIN PAULA J | EVP, Human Resources | F | Common Stock | 444 | $69.98 | 100,615.0000 | 210,530,000 | 0.44% | 0.00% |
| July 15, 2025 | SWAIN PAULA J | EVP, Human Resources | F | Common Stock | 563 | $68.25 | 100,052.0000 | 210,530,000 | 0.56% | 0.00% |
| July 15, 2025 | SWAIN PAULA J | EVP, Human Resources | A | Common Stock | 6430 | $0.00 | 106,482.0000 | 210,530,000 | 6.43% | 0.00% |
| July 15, 2025 | SWAIN PAULA J | EVP, Human Resources | A | Performance Shares | 16077 | $0.00 | 16,077.0000 | 210,530,000 | 9999.99% | 0.01% |
| July 15, 2025 | SWAIN PAULA J | EVP, Human Resources | A | Employee Stock Option (right to buy) | 14472 | $0.00 | 14,472.0000 | 210,530,000 | 9999.99% | 0.01% |
| July 14, 2025 | Stamoulis Christiana | EVP & Chief Financial Officer | F | Common Stock | 1407 | $69.98 | 116,097.0000 | 210,530,000 | 1.20% | 0.00% |
| July 15, 2025 | Stamoulis Christiana | EVP & Chief Financial Officer | F | Common Stock | 1445 | $68.25 | 114,652.0000 | 210,530,000 | 1.24% | 0.00% |
| July 15, 2025 | Stamoulis Christiana | EVP & Chief Financial Officer | A | Common Stock | 11107 | $0.00 | 125,759.0000 | 210,530,000 | 9.69% | 0.01% |
| July 15, 2025 | Stamoulis Christiana | EVP & Chief Financial Officer | A | Performance Shares | 27769 | $0.00 | 27,769.0000 | 210,530,000 | 9999.99% | 0.01% |
| July 15, 2025 | Stamoulis Christiana | EVP & Chief Financial Officer | A | Employee Stock Option (right to buy) | 24998 | $0.00 | 24,998.0000 | 210,530,000 | 9999.99% | 0.01% |
| July 14, 2025 | Tray Thomas | Principal Accounting Officer | F | Common Stock | 692 | $69.98 | 20,414.0000 | 210,530,000 | 3.28% | 0.00% |
| July 15, 2025 | Tray Thomas | Principal Accounting Officer | A | Common Stock | 4482 | $0.00 | 24,313.0000 | 210,530,000 | 22.60% | 0.00% |
| July 15, 2025 | Tray Thomas | Principal Accounting Officer | A | Employee Stock Option (right to buy) | 3362 | $0.00 | 3,362.0000 | 210,530,000 | 9999.99% | 0.00% |
| July 14, 2025 | Iyengar Vijay K | EVP, GMAPPS | F | Common Stock | 595 | $69.98 | 37,106.0000 | 210,530,000 | 1.58% | 0.00% |
| July 15, 2025 | Iyengar Vijay K | EVP, GMAPPS | S | Common Stock | 1177 | $69.86 | 35,929.0000 | 210,530,000 | 3.17% | 0.00% |
| July 15, 2025 | Iyengar Vijay K | EVP, GMAPPS | F | Common Stock | 836 | $68.25 | 35,093.0000 | 210,530,000 | 2.33% | 0.00% |
| July 15, 2025 | Iyengar Vijay K | EVP, GMAPPS | A | Common Stock | 6430 | $0.00 | 41,523.0000 | 210,530,000 | 18.32% | 0.00% |
| July 15, 2025 | Iyengar Vijay K | EVP, GMAPPS | A | Performance Shares | 16077 | $0.00 | 16,077.0000 | 210,530,000 | 9999.99% | 0.01% |
| July 15, 2025 | Iyengar Vijay K | EVP, GMAPPS | A | Employee Stock Option (right to buy) | 14472 | $0.00 | 14,472.0000 | 210,530,000 | 9999.99% | 0.01% |
| July 14, 2025 | Flannelly Barry P | EVP & General Manager US | F | Common Stock | 922 | $69.98 | 38,822.0000 | 210,530,000 | 2.32% | 0.00% |
| July 15, 2025 | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 1192 | $69.86 | 37,630.0000 | 210,530,000 | 3.07% | 0.00% |
| July 15, 2025 | Flannelly Barry P | EVP & General Manager US | F | Common Stock | 1141 | $68.25 | 36,489.0000 | 210,530,000 | 3.03% | 0.00% |
| July 14, 2025 | Hoppenot Herve | Special Advisor to the CEO | F | Common Stock | 4961 | $69.98 | 521,859.0000 | 210,530,000 | 0.94% | 0.00% |
| July 15, 2025 | Hoppenot Herve | Special Advisor to the CEO | F | Common Stock | 4713 | $68.25 | 517,146.0000 | 210,530,000 | 0.90% | 0.00% |
| July 2, 2025 | SWAIN PAULA J | EVP, Human Resources | F | Common Stock | 6285 | $68.17 | 101,059.0000 | 210,530,000 | 5.86% | 0.00% |
| July 2, 2025 | Hoppenot Herve | Special Advisor to the CEO | F | Common Stock | 42769 | $68.17 | 526,820.0000 | 210,530,000 | 7.51% | 0.02% |
| July 3, 2025 | Iyengar Vijay K | EVP, GMAPPS | S | Common Stock | 5935 | $68.15 | 37,701.0000 | 210,530,000 | 13.60% | 0.00% |
| July 3, 2025 | Iyengar Vijay K | EVP, GMAPPS | S | Common Stock | 2682 | $68.16 | 43,636.0000 | 210,530,000 | 5.79% | 0.00% |
| July 2, 2025 | Iyengar Vijay K | EVP, GMAPPS | F | Common Stock | 6809 | $68.17 | 46,318.0000 | 210,530,000 | 12.82% | 0.00% |
| July 2, 2025 | Denton Sheila A. | EVP & General Counsel | M | Employee Stock Option (right to buy) | 599 | $0.00 | 16,158.0000 | 210,530,000 | 3.57% | 0.00% |
| July 2, 2025 | Denton Sheila A. | EVP & General Counsel | S | Common Stock | 599 | $68.61 | 26,504.0000 | 210,530,000 | 2.21% | 0.00% |
| July 2, 2025 | Denton Sheila A. | EVP & General Counsel | M | Common Stock | 599 | $58.06 | 27,103.0000 | 210,530,000 | 2.26% | 0.00% |
| July 2, 2025 | Flannelly Barry P | EVP & General Manager US | F | Common Stock | 9055 | $68.17 | 50,647.0000 | 210,530,000 | 15.17% | 0.00% |
| July 3, 2025 | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 10903 | $68.15 | 39,744.0000 | 210,530,000 | 21.53% | 0.01% |
| July 2, 2025 | Tray Thomas | Principal Accounting Officer | F | Common Stock | 897 | $68.17 | 21,106.0000 | 210,530,000 | 4.08% | 0.00% |
| July 2, 2025 | Stein Steven H | EVP & Chief Medical Officer | F | Common Stock | 12714 | $68.17 | 112,418.0000 | 210,530,000 | 10.16% | 0.01% |
| July 2, 2025 | Stamoulis Christiana | EVP & Chief Financial Officer | F | Common Stock | 11589 | $68.17 | 117,504.0000 | 210,530,000 | 8.98% | 0.01% |
| June 30, 2025 | Clancy Paul J | Director | A | Common Stock | 361 | $68.10 | 22,950.0000 | 210,530,000 | 1.60% | 0.00% |
| June 30, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 492 | $0.00 | 28,780,954.0000 | 210,530,000 | 0.00% | 0.00% |
| June 30, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 492 | $0.00 | 3,410,275.0000 | 210,530,000 | 0.01% | 0.00% |
| July 2, 2025 | Meury William | Chief Executive Officer | A | Performance Shares | 125000 | $0.00 | 125,000.0000 | 210,530,000 | 9999.99% | 0.06% |
| July 2, 2025 | Meury William | Chief Executive Officer | A | Performance Shares | 108303 | $0.00 | 108,303.0000 | 210,530,000 | 9999.99% | 0.05% |
| July 2, 2025 | Meury William | Chief Executive Officer | A | Common Stock | 36101 | $0.00 | 36,101.0000 | 210,530,000 | 9999.99% | 0.02% |
| June 30, 2025 | Issa Mohamed Khairie | EVP, Head of US Oncology | A | Common Stock | 27812 | $0.00 | 76,483.0000 | 210,530,000 | 57.14% | 0.01% |
| June 30, 2025 | HARRIGAN EDMUND | Director | A | Common Stock | 367 | $68.10 | 20,319.0000 | 210,530,000 | 1.84% | 0.00% |
| June 26, 2025 | Hoppenot Herve | Special Advisor to the CEO | A | Performance Shares | 18050 | $0.00 | 18,050.0000 | 210,530,000 | 9999.99% | 0.01% |
| June 26, 2025 | Hoppenot Herve | Special Advisor to the CEO | A | Common Stock | 6016 | $0.00 | 569,589.0000 | 210,530,000 | 1.07% | 0.00% |
| June 26, 2025 | Meury William | Chief Executive Officer | A | Employee Stock Option (right to buy) | 110630 | $0.00 | 110,630.0000 | 210,530,000 | 9999.99% | 0.05% |
| June 26, 2025 | Hoppenot Herve | Special Advisor to the CEO | A | Employee Stock Option (right to buy) | 18438 | $0.00 | 18,438.0000 | 210,530,000 | 9999.99% | 0.01% |
| June 10, 2025 | BRAWLEY OTIS W | Director | A | Common Stock | 2518 | $0.00 | 11,252.0000 | 210,530,000 | 28.83% | 0.00% |
| June 10, 2025 | HARRIGAN EDMUND | Director | A | Non Qualfied Stock Option (right to buy) | 9216 | $0.00 | 9,216.0000 | 210,530,000 | 9999.99% | 0.00% |
| June 10, 2025 | HARRIGAN EDMUND | Director | A | Common Stock | 2518 | $0.00 | 19,952.0000 | 210,530,000 | 14.44% | 0.00% |
| June 10, 2025 | Schaffert Susanne | Director | A | Non Qualfied Stock Option (right to buy) | 9216 | $0.00 | 9,216.0000 | 210,530,000 | 9999.99% | 0.00% |
| June 10, 2025 | Schaffert Susanne | Director | A | Common Stock | 2518 | $0.00 | 7,389.0000 | 210,530,000 | 51.69% | 0.00% |
| June 10, 2025 | Schaffert Susanne | Director | F | Common Stock | 849 | $70.07 | 4,871.0000 | 210,530,000 | 14.84% | 0.00% |
| June 10, 2025 | Clancy Paul J | Director | A | Non Qualfied Stock Option (right to buy) | 9216 | $0.00 | 9,216.0000 | 210,530,000 | 9999.99% | 0.00% |
| June 10, 2025 | Clancy Paul J | Director | A | Common Stock | 2518 | $0.00 | 22,589.0000 | 210,530,000 | 12.55% | 0.00% |
| June 10, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 9216 | $0.00 | 9,216.0000 | 210,530,000 | 9999.99% | 0.00% |
| June 10, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 9216 | $0.00 | 9,216.0000 | 210,530,000 | 9999.99% | 0.00% |
| June 10, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 2518 | $0.00 | 28,780,462.0000 | 210,530,000 | 0.01% | 0.00% |
| June 10, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 2518 | $0.00 | 3,409,783.0000 | 210,530,000 | 0.07% | 0.00% |
| June 10, 2025 | High Katherine A | Director | A | Non Qualfied Stock Option (right to buy) | 9216 | $0.00 | 9,216.0000 | 210,530,000 | 9999.99% | 0.00% |
| June 10, 2025 | High Katherine A | Director | A | Common Stock | 2518 | $0.00 | 13,341.0000 | 210,530,000 | 23.27% | 0.00% |
| June 10, 2025 | BIENAIME JEAN JACQUES | Director | A | Non Qualfied Stock Option (right to buy) | 9216 | $0.00 | 9,216.0000 | 210,530,000 | 9999.99% | 0.00% |
| June 10, 2025 | BIENAIME JEAN JACQUES | Director | A | Common Stock | 2518 | $0.00 | 20,841.0000 | 210,530,000 | 13.74% | 0.00% |
| June 10, 2025 | FOUSE JACQUALYN A | Director | A | Non Qualfied Stock Option (right to buy) | 9216 | $0.00 | 9,216.0000 | 210,530,000 | 9999.99% | 0.00% |
| June 10, 2025 | FOUSE JACQUALYN A | Director | A | Common Stock | 2518 | $0.00 | 19,326.0000 | 210,530,000 | 14.98% | 0.00% |
| June 10, 2025 | BRAWLEY OTIS W | Director | A | Non Qualfied Stock Option (right to buy) | 9216 | $0.00 | 9,216.0000 | 210,530,000 | 9999.99% | 0.00% |
| June 3, 2025 | Denton Sheila A. | EVP & General Counsel | M | Common Stock | 1795 | $58.06 | 28,299.0000 | 210,530,000 | 6.77% | 0.00% |
| June 3, 2025 | Denton Sheila A. | EVP & General Counsel | S | Common Stock | 1795 | $68.00 | 26,504.0000 | 210,530,000 | 6.34% | 0.00% |
| June 3, 2025 | Denton Sheila A. | EVP & General Counsel | M | Employee Stock Option (right to buy) | 1795 | $0.00 | 16,757.0000 | 210,530,000 | 9.68% | 0.00% |
| May 30, 2025 | Tray Thomas | Principal Accounting Officer | S | Common Stock | 963 | $65.71 | 22,654.0000 | 210,530,000 | 4.08% | 0.00% |
| June 2, 2025 | Tray Thomas | Principal Accounting Officer | S | Common Stock | 651 | $64.88 | 22,003.0000 | 210,530,000 | 2.87% | 0.00% |
| April 1, 2025 | Iyengar Vijay K | EVP, GMAPPS | A | Common Stock | 10982 | $0.00 | 52,799.0000 | 210,530,000 | 26.26% | 0.01% |
| April 1, 2025 | Flannelly Barry P | EVP & General Manager US | A | Common Stock | 11159 | $0.00 | 44,726.0000 | 210,530,000 | 33.24% | 0.01% |
| April 1, 2025 | Flannelly Barry P | EVP & General Manager US | A | Common Stock | 14976 | $0.00 | 59,702.0000 | 210,530,000 | 33.48% | 0.01% |
| April 1, 2025 | Iyengar Vijay K | EVP, GMAPPS | A | Common Stock | 11159 | $0.00 | 41,817.0000 | 210,530,000 | 36.40% | 0.01% |
| April 1, 2025 | Morrissey Michael James | EVP, Head of Tech. Operations | A | Common Stock | 4649 | $0.00 | 86,164.0000 | 210,530,000 | 5.70% | 0.00% |
| April 1, 2025 | Stamoulis Christiana | EVP & Chief Financial Officer | A | Common Stock | 18598 | $0.00 | 110,123.0000 | 210,530,000 | 20.32% | 0.01% |
| April 1, 2025 | Stamoulis Christiana | EVP & Chief Financial Officer | A | Common Stock | 18970 | $0.00 | 129,093.0000 | 210,530,000 | 17.23% | 0.01% |
| April 1, 2025 | Stein Steven H | EVP & Chief Medical Officer | A | Common Stock | 37198 | $0.00 | 104,165.0000 | 210,530,000 | 55.55% | 0.02% |
| April 1, 2025 | Stein Steven H | EVP & Chief Medical Officer | A | Common Stock | 20967 | $0.00 | 125,132.0000 | 210,530,000 | 20.13% | 0.01% |
| April 1, 2025 | SWAIN PAULA J | EVP, Human Resources | A | Common Stock | 11159 | $0.00 | 96,362.0000 | 210,530,000 | 13.10% | 0.01% |
| April 1, 2025 | SWAIN PAULA J | EVP, Human Resources | A | Common Stock | 10982 | $0.00 | 107,344.0000 | 210,530,000 | 11.40% | 0.01% |
| April 1, 2025 | Hoppenot Herve | Chairman / CEO | A | Common Stock | 66899 | $0.00 | 563,573.0000 | 210,530,000 | 13.47% | 0.03% |
| March 31, 2025 | HARRIGAN EDMUND | Director | A | Common Stock | 363 | $60.55 | 17,434.0000 | 210,530,000 | 2.13% | 0.00% |
| March 31, 2025 | Clancy Paul J | Director | A | Common Stock | 358 | $60.55 | 20,071.0000 | 210,530,000 | 1.82% | 0.00% |
| March 31, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 487 | $0.00 | 28,777,944.0000 | 210,530,000 | 0.00% | 0.00% |
| March 31, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 487 | $0.00 | 3,407,265.0000 | 210,530,000 | 0.01% | 0.00% |
| March 25, 2025 | Trotta Matteo | EVP, GM, Dermatology US | F | Common Stock | 537 | $62.08 | 9,937.0000 | 210,530,000 | 5.13% | 0.00% |
| March 14, 2025 | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 199 | $67.88 | 52,714.0000 | 210,530,000 | 0.38% | 0.00% |
| March 14, 2025 | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 19147 | $67.68 | 33,567.0000 | 210,530,000 | 36.32% | 0.01% |
| March 14, 2025 | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 461 | $67.85 | 52,913.0000 | 210,530,000 | 0.86% | 0.00% |
| March 4, 2025 | Denton Sheila A. | EVP & General Counsel | S | Common Stock | 599 | $69.99 | 25,848.0000 | 210,530,000 | 2.26% | 0.00% |
| March 4, 2025 | Denton Sheila A. | EVP & General Counsel | M | Employee Stock Option (right to buy) | 599 | $0.00 | 18,552.0000 | 210,530,000 | 3.13% | 0.00% |
| March 4, 2025 | Denton Sheila A. | EVP & General Counsel | M | Common Stock | 599 | $58.06 | 26,447.0000 | 210,530,000 | 2.32% | 0.00% |
| Feb. 26, 2025 | Denton Sheila A. | EVP & General Counsel | S | Common Stock | 9574 | $74.07 | 30,343.0000 | 210,530,000 | 23.98% | 0.00% |
| Feb. 26, 2025 | Denton Sheila A. | EVP & General Counsel | M | Common Stock | 9574 | $58.06 | 39,917.0000 | 210,530,000 | 31.55% | 0.00% |
| Feb. 26, 2025 | Denton Sheila A. | EVP & General Counsel | M | Employee Stock Option (right to buy) | 9574 | $0.00 | 19,151.0000 | 210,530,000 | 33.33% | 0.00% |
| Feb. 26, 2025 | Denton Sheila A. | EVP & General Counsel | S | Common Stock | 4495 | $74.08 | 25,848.0000 | 210,530,000 | 14.81% | 0.00% |
| Jan. 31, 2025 | Morrissey Michael James | EVP, Head of Tech. Operations | A | Common Stock | 10552 | $0.00 | 81,515.0000 | 210,530,000 | 14.87% | 0.01% |
| Jan. 31, 2025 | Heeson Lee | EVP, Head of Incyte Intl | A | Common Stock | 6331 | $0.00 | 32,778.0000 | 210,530,000 | 23.94% | 0.00% |
| Jan. 17, 2025 | Stamoulis Christiana | EVP & Chief Financial Officer | A | Employee Stock Option (right to buy) | 25516 | $0.00 | 25,516.0000 | 210,530,000 | 9999.99% | 0.01% |
| Jan. 17, 2025 | Flannelly Barry P | EVP & General Manager US | A | Employee Stock Option (right to buy) | 20144 | $0.00 | 20,144.0000 | 210,530,000 | 9999.99% | 0.01% |
| Jan. 17, 2025 | Hoppenot Herve | Chairman / CEO | A | Employee Stock Option (right to buy) | 55510 | $0.00 | 55,510.0000 | 210,530,000 | 9999.99% | 0.03% |
| Jan. 17, 2025 | Tray Thomas | Principal Accounting Officer | A | Employee Stock Option (right to buy) | 3432 | $0.00 | 3,432.0000 | 210,530,000 | 9999.99% | 0.00% |
| Jan. 17, 2025 | CAGNONI PABLO J | President, R&D | A | Employee Stock Option (right to buy) | 40289 | $0.00 | 40,289.0000 | 210,530,000 | 9999.99% | 0.02% |
| Jan. 17, 2025 | Denton Sheila A. | EVP & General Counsel | A | Employee Stock Option (right to buy) | 12086 | $0.00 | 12,086.0000 | 210,530,000 | 9999.99% | 0.01% |
| Jan. 17, 2025 | Trotta Matteo | EVP, GM, Dermatology US | A | Employee Stock Option (right to buy) | 5371 | $0.00 | 5,371.0000 | 210,530,000 | 9999.99% | 0.00% |
| Jan. 21, 2025 | Stein Steven H | EVP & Chief Medical Officer | S | Common Stock | 12352 | $72.69 | 66,967.0000 | 210,530,000 | 15.57% | 0.01% |
| Jan. 17, 2025 | Stein Steven H | EVP & Chief Medical Officer | A | Employee Stock Option (right to buy) | 28202 | $0.00 | 28,202.0000 | 210,530,000 | 9999.99% | 0.01% |
| Jan. 21, 2025 | Morrissey Michael James | EVP, Head of Tech. Operations | F | Common Stock | 429 | $73.47 | 70,963.0000 | 210,530,000 | 0.60% | 0.00% |
| Jan. 17, 2025 | SWAIN PAULA J | EVP, Human Resources | A | Employee Stock Option (right to buy) | 14772 | $0.00 | 14,772.0000 | 210,530,000 | 9999.99% | 0.01% |
| Jan. 17, 2025 | Iyengar Vijay K | EVP, GMAPPS | A | Employee Stock Option (right to buy) | 14772 | $0.00 | 14,772.0000 | 210,530,000 | 9999.99% | 0.01% |
| Jan. 15, 2025 | Morrissey Michael James | EVP, Head of Tech. Operations | F | Common Stock | 908 | $72.46 | 71,392.0000 | 210,530,000 | 1.26% | 0.00% |
| Jan. 15, 2025 | Flannelly Barry P | EVP & General Manager US | F | Common Stock | 3158 | $72.46 | 53,374.0000 | 210,530,000 | 5.59% | 0.00% |
| Jan. 15, 2025 | Stein Steven H | EVP & Chief Medical Officer | F | Common Stock | 10692 | $72.46 | 79,319.0000 | 210,530,000 | 11.88% | 0.01% |
| Jan. 15, 2025 | Stamoulis Christiana | EVP & Chief Financial Officer | F | Common Stock | 3672 | $72.46 | 91,525.0000 | 210,530,000 | 3.86% | 0.00% |
| Jan. 6, 2025 | Issa Mohamed Khairie | EVP, Head of US Oncology | A | Common Stock | 48671 | $0.00 | 48,671.0000 | 210,530,000 | 9999.99% | 0.02% |
| Dec. 31, 2024 | Clancy Paul J | Director | A | Common Stock | 331 | $69.07 | 19,713.0000 | 211,763,000 | 1.71% | 0.00% |
| Dec. 31, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 446 | $0.00 | 3,406,778.0000 | 211,763,000 | 0.01% | 0.00% |
| Dec. 31, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 446 | $0.00 | 28,777,457.0000 | 211,763,000 | 0.00% | 0.00% |
| Dec. 31, 2024 | HARRIGAN EDMUND | Director | A | Common Stock | 339 | $69.07 | 17,071.0000 | 211,763,000 | 2.03% | 0.00% |
| Dec. 13, 2024 | Tray Thomas | Principal Accounting Officer | S | Common Stock | 650 | $70.64 | 23,962.0000 | 211,763,000 | 2.64% | 0.00% |
| Dec. 16, 2024 | Tray Thomas | Principal Accounting Officer | S | Common Stock | 650 | $69.31 | 23,312.0000 | 211,763,000 | 2.71% | 0.00% |
| Dec. 9, 2024 | SWAIN PAULA J | EVP, Human Resources | F | Common Stock | 873 | $72.11 | 85,203.0000 | 211,763,000 | 1.01% | 0.00% |
| Dec. 9, 2024 | Flannelly Barry P | EVP & General Manager US | F | Common Stock | 1510 | $72.11 | 56,532.0000 | 211,763,000 | 2.60% | 0.00% |
| Nov. 29, 2024 | Iyengar Vijay K | EVP, GMAPPS | S | Common Stock | 5683 | $75.37 | 30,658.0000 | 211,763,000 | 15.64% | 0.00% |
| Nov. 29, 2024 | Iyengar Vijay K | EVP, GMAPPS | S | Common Stock | 360 | $75.60 | 36,341.0000 | 211,763,000 | 0.98% | 0.00% |
| Nov. 6, 2024 | Flannelly Barry P | EVP & General Manager US | M | Employee Stock Option (right to buy) | 1424 | $0.00 | 0.0000 | 211,763,000 | 100.00% | 0.00% |
| Nov. 6, 2024 | Flannelly Barry P | EVP & General Manager US | M | Employee Stock Option (right to buy) | 2256 | $0.00 | 0.0000 | 211,763,000 | 100.00% | 0.00% |
| Nov. 6, 2024 | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 1424 | $82.00 | 60,298.0000 | 211,763,000 | 2.31% | 0.00% |
| Nov. 6, 2024 | Flannelly Barry P | EVP & General Manager US | M | Common Stock | 1424 | $72.27 | 59,466.0000 | 211,763,000 | 2.45% | 0.00% |
| Nov. 6, 2024 | Flannelly Barry P | EVP & General Manager US | M | Common Stock | 2256 | $68.62 | 61,722.0000 | 211,763,000 | 3.79% | 0.00% |
| Nov. 6, 2024 | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 2256 | $78.21 | 58,042.0000 | 211,763,000 | 3.74% | 0.00% |
| Oct. 2, 2024 | Denton Sheila A. | EVP & General Counsel | F | Common Stock | 2136 | $67.63 | 30,343.0000 | 211,763,000 | 6.58% | 0.00% |
| Oct. 1, 2024 | Heeson Lee | EVP, Head of Incyte Intl | A | Common Stock | 26447 | $0.00 | 26,447.0000 | 211,763,000 | 9999.99% | 0.01% |
| Sept. 30, 2024 | Clancy Paul J | Director | A | Common Stock | 368 | $66.10 | 19,382.0000 | 225,928,000 | 1.94% | 0.00% |
| Sept. 30, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 496 | $0.00 | 28,777,011.0000 | 225,928,000 | 0.00% | 0.00% |
| Sept. 30, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 496 | $0.00 | 3,406,332.0000 | 225,928,000 | 0.01% | 0.00% |
| Sept. 30, 2024 | HARRIGAN EDMUND | Director | A | Common Stock | 378 | $66.10 | 16,732.0000 | 225,928,000 | 2.31% | 0.00% |
| Sept. 12, 2024 | Dickinson Jonathan Elliott | EVP, General Manager, Europe | S | Common Stock | 7333 | $62.37 | 36,390.0000 | 225,928,000 | 16.77% | 0.00% |
| Sept. 12, 2024 | Dickinson Jonathan Elliott | EVP, General Manager, Europe | S | Common Stock | 1117 | $62.30 | 43,723.0000 | 225,928,000 | 2.49% | 0.00% |
| Sept. 13, 2024 | Tray Thomas | Principal Accounting Officer | S | Common Stock | 382 | $63.37 | 24,443.0000 | 225,928,000 | 1.54% | 0.00% |
| Sept. 12, 2024 | Tray Thomas | Principal Accounting Officer | S | Common Stock | 572 | $62.94 | 24,825.0000 | 225,928,000 | 2.25% | 0.00% |
| Aug. 12, 2024 | Stein Steven H | EVP & Chief Medical Officer | S | Common Stock | 11608 | $60.63 | 90,011.0000 | 225,928,000 | 11.42% | 0.01% |
| July 25, 2024 | Iyengar Vijay K | EVP, GMAPPS | S | Common Stock | 15571 | $70.00 | 36,701.0000 | 225,928,000 | 29.79% | 0.01% |
| July 15, 2024 | Stein Steven H | EVP & Chief Medical Officer | A | Employee Stock Option (right to buy) | 31088 | $0.00 | 31,088.0000 | 225,928,000 | 9999.99% | 0.01% |
| July 15, 2024 | Stein Steven H | EVP & Chief Medical Officer | A | Common Stock | 13895 | $0.00 | 103,174.0000 | 225,928,000 | 15.56% | 0.01% |
| July 15, 2024 | Stein Steven H | EVP & Chief Medical Officer | F | Common Stock | 1555 | $64.25 | 101,619.0000 | 225,928,000 | 1.51% | 0.00% |
| July 15, 2024 | Tray Thomas | Principal Accounting Officer | A | Common Stock | 5073 | $0.00 | 25,863.0000 | 225,928,000 | 24.40% | 0.00% |
| July 15, 2024 | Tray Thomas | Principal Accounting Officer | F | Common Stock | 466 | $64.25 | 25,397.0000 | 225,928,000 | 1.80% | 0.00% |
| July 15, 2024 | Tray Thomas | Principal Accounting Officer | A | Employee Stock Option (right to buy) | 3783 | $0.00 | 3,783.0000 | 225,928,000 | 9999.99% | 0.00% |
| July 15, 2024 | SWAIN PAULA J | EVP, Human Resources | A | Common Stock | 7278 | $0.00 | 86,625.0000 | 225,928,000 | 9.17% | 0.00% |
| July 15, 2024 | SWAIN PAULA J | EVP, Human Resources | F | Common Stock | 549 | $64.25 | 86,076.0000 | 225,928,000 | 0.63% | 0.00% |
| July 15, 2024 | SWAIN PAULA J | EVP, Human Resources | A | Employee Stock Option (right to buy) | 16284 | $0.00 | 16,284.0000 | 225,928,000 | 9999.99% | 0.01% |
| July 15, 2024 | Denton Sheila A. | EVP & General Counsel | A | Common Stock | 5955 | $0.00 | 32,479.0000 | 225,928,000 | 22.45% | 0.00% |
| July 15, 2024 | Denton Sheila A. | EVP & General Counsel | A | Employee Stock Option (right to buy) | 13323 | $0.00 | 13,323.0000 | 225,928,000 | 9999.99% | 0.01% |
| July 15, 2024 | Trotta Matteo | EVP, GM, Dermatology US | A | Common Stock | 2646 | $0.00 | 10,474.0000 | 225,928,000 | 33.80% | 0.00% |
| July 15, 2024 | Trotta Matteo | EVP, GM, Dermatology US | A | Employee Stock Option (right to buy) | 5921 | $0.00 | 5,921.0000 | 225,928,000 | 9999.99% | 0.00% |
| July 15, 2024 | CAGNONI PABLO J | President, R&D | A | Common Stock | 19851 | $0.00 | 221,919.0000 | 225,928,000 | 9.82% | 0.01% |
| July 15, 2024 | CAGNONI PABLO J | President, R&D | F | Common Stock | 749 | $64.25 | 221,170.0000 | 225,928,000 | 0.34% | 0.00% |
| July 15, 2024 | CAGNONI PABLO J | President, R&D | A | Employee Stock Option (right to buy) | 44411 | $0.00 | 44,411.0000 | 225,928,000 | 9999.99% | 0.02% |
| July 15, 2024 | Hoppenot Herve | Chairman / CEO | A | Common Stock | 41025 | $0.00 | 501,635.0000 | 225,928,000 | 8.91% | 0.02% |
| July 15, 2024 | Hoppenot Herve | Chairman / CEO | F | Common Stock | 4961 | $64.25 | 496,674.0000 | 225,928,000 | 0.99% | 0.00% |
| July 15, 2024 | Hoppenot Herve | Chairman / CEO | A | Employee Stock Option (right to buy) | 61189 | $0.00 | 61,189.0000 | 225,928,000 | 9999.99% | 0.03% |
| July 15, 2024 | Iyengar Vijay K | EVP, GMAPPS | A | Common Stock | 7278 | $0.00 | 52,821.0000 | 225,928,000 | 15.98% | 0.00% |
| July 15, 2024 | Iyengar Vijay K | EVP, GMAPPS | F | Common Stock | 549 | $64.25 | 52,272.0000 | 225,928,000 | 1.04% | 0.00% |
| July 15, 2024 | Iyengar Vijay K | EVP, GMAPPS | A | Employee Stock Option (right to buy) | 16284 | $0.00 | 16,284.0000 | 225,928,000 | 9999.99% | 0.01% |
| July 15, 2024 | Stamoulis Christiana | EVP & Chief Financial Officer | A | Common Stock | 12572 | $0.00 | 96,145.0000 | 225,928,000 | 15.04% | 0.01% |
| July 15, 2024 | Stamoulis Christiana | EVP & Chief Financial Officer | F | Common Stock | 948 | $64.25 | 95,197.0000 | 225,928,000 | 0.99% | 0.00% |
| July 15, 2024 | Stamoulis Christiana | EVP & Chief Financial Officer | A | Employee Stock Option (right to buy) | 28127 | $0.00 | 28,127.0000 | 225,928,000 | 9999.99% | 0.01% |
| July 15, 2024 | Flannelly Barry P | EVP & General Manager US | A | Common Stock | 9925 | $0.00 | 60,459.0000 | 225,928,000 | 19.64% | 0.00% |
| July 15, 2024 | Flannelly Barry P | EVP & General Manager US | F | Common Stock | 1111 | $64.25 | 59,348.0000 | 225,928,000 | 1.84% | 0.00% |
| July 16, 2024 | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 1306 | $64.19 | 58,042.0000 | 225,928,000 | 2.20% | 0.00% |
| July 15, 2024 | Flannelly Barry P | EVP & General Manager US | A | Employee Stock Option (right to buy) | 22205 | $0.00 | 22,205.0000 | 225,928,000 | 9999.99% | 0.01% |
| July 9, 2024 | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 8148 | $60.00 | 50,534.0000 | 225,928,000 | 13.89% | 0.00% |
| July 2, 2024 | SWAIN PAULA J | EVP, Human Resources | F | Common Stock | 5560 | $59.02 | 79,347.0000 | 225,928,000 | 6.55% | 0.00% |
| July 2, 2024 | Tray Thomas | Principal Accounting Officer | F | Common Stock | 844 | $59.02 | 20,790.0000 | 225,928,000 | 3.90% | 0.00% |
| July 2, 2024 | Hoppenot Herve | Chairman / CEO | F | Common Stock | 41723 | $59.02 | 460,610.0000 | 225,928,000 | 8.31% | 0.02% |
| July 2, 2024 | Flannelly Barry P | EVP & General Manager US | F | Common Stock | 7695 | $59.02 | 58,682.0000 | 225,928,000 | 11.59% | 0.00% |
| July 2, 2024 | Iyengar Vijay K | EVP, GMAPPS | F | Common Stock | 5706 | $59.02 | 45,543.0000 | 225,928,000 | 11.13% | 0.00% |
| July 2, 2024 | Stein Steven H | EVP & Chief Medical Officer | F | Common Stock | 8316 | $59.02 | 89,279.0000 | 225,928,000 | 8.52% | 0.00% |
| July 2, 2024 | Stamoulis Christiana | EVP & Chief Financial Officer | F | Common Stock | 6870 | $59.02 | 83,573.0000 | 225,928,000 | 7.60% | 0.00% |
| June 28, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 537 | $0.00 | 3,405,836.0000 | 225,928,000 | 0.02% | 0.00% |
| June 28, 2024 | Clancy Paul J | Director | A | Common Stock | 399 | $60.62 | 19,014.0000 | 225,928,000 | 2.14% | 0.00% |
| June 28, 2024 | HARRIGAN EDMUND | Director | A | Common Stock | 409 | $60.62 | 16,354.0000 | 225,928,000 | 2.57% | 0.00% |
| June 28, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 537 | $0.00 | 28,776,515.0000 | 225,928,000 | 0.00% | 0.00% |
| June 12, 2024 | High Katherine A | Director | A | Common Stock | 2830 | $0.00 | 10,823.0000 | 225,928,000 | 35.41% | 0.00% |
| June 12, 2024 | High Katherine A | Director | A | Non Qualfied Stock Option (right to buy) | 12517 | $0.00 | 12,517.0000 | 225,928,000 | 9999.99% | 0.01% |
| June 12, 2024 | BRAWLEY OTIS W | Director | A | Common Stock | 2830 | $0.00 | 8,734.0000 | 225,928,000 | 47.93% | 0.00% |
| June 12, 2024 | BRAWLEY OTIS W | Director | A | Non Qualfied Stock Option (right to buy) | 12517 | $0.00 | 12,517.0000 | 225,928,000 | 9999.99% | 0.01% |
| June 12, 2024 | Schaffert Susanne | Director | F | Common Stock | 752 | $59.94 | 2,890.0000 | 225,928,000 | 20.65% | 0.00% |
| June 12, 2024 | Schaffert Susanne | Director | A | Common Stock | 2830 | $0.00 | 5,720.0000 | 225,928,000 | 97.92% | 0.00% |
| June 12, 2024 | Schaffert Susanne | Director | A | Non Qualfied Stock Option (right to buy) | 12517 | $0.00 | 12,517.0000 | 225,928,000 | 9999.99% | 0.01% |
| June 12, 2024 | HARRIGAN EDMUND | Director | A | Common Stock | 2830 | $0.00 | 15,945.0000 | 225,928,000 | 21.58% | 0.00% |
| June 12, 2024 | HARRIGAN EDMUND | Director | A | Non Qualfied Stock Option (right to buy) | 12517 | $0.00 | 12,517.0000 | 225,928,000 | 9999.99% | 0.01% |
| June 12, 2024 | Clancy Paul J | Director | A | Common Stock | 2830 | $0.00 | 18,615.0000 | 225,928,000 | 17.93% | 0.00% |
| June 12, 2024 | Clancy Paul J | Director | A | Non Qualfied Stock Option (right to buy) | 12517 | $0.00 | 12,517.0000 | 225,928,000 | 9999.99% | 0.01% |
| June 12, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 2830 | $0.00 | 3,581,276.0000 | 225,928,000 | 0.08% | 0.00% |
| June 12, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 2830 | $0.00 | 34,059,184.0000 | 225,928,000 | 0.01% | 0.00% |
| June 12, 2024 | BAKER BROS. ADVISORS LP | Not found | D | Common Stock | 175977 | $60.00 | 3,405,299.0000 | 225,928,000 | 4.91% | 0.08% |
| June 12, 2024 | BAKER BROS. ADVISORS LP | Not found | D | Common Stock | 5283206 | $60.00 | 28,775,978.0000 | 225,928,000 | 15.51% | 2.34% |
| June 12, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 12517 | $0.00 | 12,517.0000 | 225,928,000 | 9999.99% | 0.01% |
| June 12, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Options (right to buy) | 12517 | $0.00 | 12,517.0000 | 225,928,000 | 9999.99% | 0.01% |
| June 12, 2024 | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 19164 | $60.00 | 66,377.0000 | 225,928,000 | 22.40% | 0.01% |
| June 12, 2024 | BIENAIME JEAN JACQUES | Director | A | Common Stock | 2830 | $0.00 | 18,323.0000 | 225,928,000 | 18.27% | 0.00% |
| June 12, 2024 | BIENAIME JEAN JACQUES | Director | A | Non Qualfied Stock Option (right to buy) | 12517 | $0.00 | 12,517.0000 | 225,928,000 | 9999.99% | 0.01% |
| June 12, 2024 | FOUSE JACQUALYN A | Director | A | Common Stock | 2830 | $0.00 | 16,808.0000 | 225,928,000 | 20.25% | 0.00% |
| June 12, 2024 | FOUSE JACQUALYN A | Director | A | Non Qualfied Stock Option (right to buy) | 12517 | $0.00 | 12,517.0000 | 225,928,000 | 9999.99% | 0.01% |
| June 6, 2024 | Tray Thomas | Principal Accounting Officer | S | Common Stock | 1093 | $58.91 | 21,634.0000 | 225,928,000 | 4.81% | 0.00% |
| May 7, 2024 | BAKER BROS. ADVISORS LP | Not found | M | Non- Qualified Stock Options (right to buy) | 15000 | $0.00 | 0.0000 | 225,928,000 | 100.00% | 0.01% |
| May 7, 2024 | BAKER BROS. ADVISORS LP | Not found | M | Non- Qualified Stock Options (right to buy) | 15000 | $0.00 | 0.0000 | 225,928,000 | 100.00% | 0.01% |
| May 7, 2024 | BAKER BROS. ADVISORS LP | Not found | M | Common Stock | 15000 | $49.01 | 34,056,354.0000 | 225,928,000 | 0.04% | 0.01% |
| May 7, 2024 | BAKER BROS. ADVISORS LP | Not found | M | Common Stock | 15000 | $49.01 | 3,578,446.0000 | 225,928,000 | 0.42% | 0.01% |
| March 28, 2024 | Clancy Paul J | Director | A | Common Stock | 403 | $56.97 | 15,785.0000 | 225,928,000 | 2.62% | 0.00% |
| March 28, 2024 | HARRIGAN EDMUND | Director | A | Common Stock | 413 | $56.97 | 13,115.0000 | 225,928,000 | 3.25% | 0.00% |
| March 28, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 543 | $0.00 | 3,563,446.0000 | 225,928,000 | 0.02% | 0.00% |
| March 28, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 543 | $0.00 | 34,041,354.0000 | 225,928,000 | 0.00% | 0.00% |
| March 25, 2024 | Trotta Matteo | EVP, GM, Dermatology US | A | Employee Stock Option (right to buy) | 21868 | $0.00 | 21,868.0000 | 225,928,000 | 9999.99% | 0.01% |
| March 25, 2024 | Trotta Matteo | EVP, GM, Dermatology US | A | Common Stock | 7828 | $0.00 | 7,828.0000 | 225,928,000 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Flannelly Barry P | EVP & General Manager US | A | Common Stock | 7377 | $0.00 | 85,080.0000 | 225,928,000 | 9.49% | 0.00% |
| Feb. 14, 2024 | Hoppenot Herve | Chairman / CEO | A | Common Stock | 41577 | $0.00 | 502,333.0000 | 225,928,000 | 9.02% | 0.02% |
| Feb. 14, 2024 | SWAIN PAULA J | EVP, Human Resources | A | Common Stock | 7377 | $0.00 | 84,907.0000 | 225,928,000 | 9.52% | 0.00% |
| Feb. 14, 2024 | Stein Steven H | EVP & Chief Medical Officer | A | Common Stock | 7377 | $0.00 | 97,595.0000 | 225,928,000 | 8.18% | 0.00% |
| Feb. 14, 2024 | Stamoulis Christiana | EVP & Chief Financial Officer | A | Common Stock | 7377 | $0.00 | 89,983.0000 | 225,928,000 | 8.93% | 0.00% |
| Feb. 14, 2024 | Iyengar Vijay K | EVP, GMAPPS | A | Common Stock | 7377 | $0.00 | 50,789.0000 | 225,928,000 | 16.99% | 0.00% |
| Feb. 12, 2024 | Stamoulis Christiana | EVP & Chief Financial Officer | F | Common Stock | 387 | $57.84 | 82,606.0000 | 225,928,000 | 0.47% | 0.00% |
| Jan. 22, 2024 | Morrissey Michael James | EVP, Head of Tech. Operations | F | Common Stock | 108 | $61.50 | 72,300.0000 | 225,928,000 | 0.15% | 0.00% |
| Jan. 22, 2024 | Dickinson Jonathan Elliott | EVP, General Manager, Europe | F | Common Stock | 108 | $61.50 | 44,380.0000 | 225,928,000 | 0.24% | 0.00% |
| Jan. 18, 2024 | Dickinson Jonathan Elliott | EVP, General Manager, Europe | A | Common Stock | 8114 | $61.18 | 44,610.0000 | 225,928,000 | 22.23% | 0.00% |
| Jan. 18, 2024 | CAGNONI PABLO J | President, R&D | A | Employee Stock Option (right to buy) | 21843 | $0.00 | 21,843.0000 | 225,928,000 | 9999.99% | 0.01% |
| Jan. 18, 2024 | Morrissey Michael James | EVP, Head of Tech. Operations | A | Common Stock | 11359 | $61.18 | 72,530.0000 | 225,928,000 | 18.57% | 0.01% |
| Jan. 19, 2024 | Morrissey Michael James | EVP, Head of Tech. Operations | F | Common Stock | 122 | $61.49 | 72,408.0000 | 225,928,000 | 0.17% | 0.00% |
| Jan. 19, 2024 | Dickinson Jonathan Elliott | EVP, General Manager, Europe | F | Common Stock | 122 | $61.49 | 44,488.0000 | 225,928,000 | 0.27% | 0.00% |
| Jan. 18, 2024 | SWAIN PAULA J | EVP, Human Resources | A | Employee Stock Option (right to buy) | 16018 | $0.00 | 16,018.0000 | 225,928,000 | 9999.99% | 0.01% |
| Jan. 18, 2024 | Stein Steven H | EVP & Chief Medical Officer | A | Employee Stock Option (right to buy) | 30580 | $0.00 | 30,580.0000 | 225,928,000 | 9999.99% | 0.01% |
| Jan. 18, 2024 | Iyengar Vijay K | EVP, GMAPPS | A | Employee Stock Option (right to buy) | 16018 | $0.00 | 16,018.0000 | 225,928,000 | 9999.99% | 0.01% |
| Jan. 18, 2024 | Stamoulis Christiana | EVP & Chief Financial Officer | A | Employee Stock Option (right to buy) | 27668 | $0.00 | 27,668.0000 | 225,928,000 | 9999.99% | 0.01% |
| Jan. 18, 2024 | Flannelly Barry P | EVP & General Manager US | A | Employee Stock Option (right to buy) | 21843 | $0.00 | 21,843.0000 | 225,928,000 | 9999.99% | 0.01% |
| Jan. 18, 2024 | Hoppenot Herve | Chairman / CEO | A | Employee Stock Option (right to buy) | 97566 | $0.00 | 97,566.0000 | 225,928,000 | 9999.99% | 0.04% |
| Jan. 18, 2024 | Tray Thomas | Principal Accounting Officer | A | Employee Stock Option (right to buy) | 4530 | $0.00 | 4,530.0000 | 225,928,000 | 9999.99% | 0.00% |
| Jan. 17, 2024 | Flannelly Barry P | EVP & General Manager US | F | Common Stock | 3675 | $61.48 | 77,703.0000 | 225,928,000 | 4.52% | 0.00% |
| Jan. 17, 2024 | Tray Thomas | Principal Accounting Officer | F | Common Stock | 1021 | $61.48 | 22,415.0000 | 225,928,000 | 4.36% | 0.00% |
| Jan. 17, 2024 | Morrissey Michael James | EVP, Head of Tech. Operations | F | Common Stock | 101 | $61.48 | 61,171.0000 | 225,928,000 | 0.16% | 0.00% |
| Jan. 16, 2024 | Dickinson Jonathan Elliott | EVP, General Manager, Europe | F | Common Stock | 101 | $61.34 | 36,597.0000 | 225,928,000 | 0.28% | 0.00% |
| Jan. 17, 2024 | Dickinson Jonathan Elliott | EVP, General Manager, Europe | F | Common Stock | 101 | $61.48 | 36,496.0000 | 225,928,000 | 0.28% | 0.00% |
| Jan. 16, 2024 | Morrissey Michael James | EVP, Head of Tech. Operations | F | Common Stock | 101 | $61.34 | 61,272.0000 | 225,928,000 | 0.16% | 0.00% |
| Jan. 3, 2024 | Stein Steven H | EVP & Chief Medical Officer | S | Common Stock | 7365 | $65.51 | 90,218.0000 | 225,928,000 | 7.55% | 0.00% |
| Jan. 2, 2024 | Iyengar Vijay K | EVP, GMAPPS | S | Common Stock | 657 | $65.00 | 43,412.0000 | 225,928,000 | 1.49% | 0.00% |
| Dec. 29, 2023 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 556 | $0.00 | 34,040,811.0000 | 223,958,000 | 0.00% | 0.00% |
| Dec. 29, 2023 | HARRIGAN EDMUND | Director | A | Common Stock | 423 | $62.79 | 12,702.0000 | 223,958,000 | 3.44% | 0.00% |
| Dec. 29, 2023 | Clancy Paul J | Director | A | Common Stock | 412 | $62.79 | 15,382.0000 | 223,958,000 | 2.75% | 0.00% |
| Dec. 29, 2023 | BAKER BROS. ADVISORS LP | Not found | A | Common Stock | 556 | $0.00 | 3,562,903.0000 | 223,958,000 | 0.02% | 0.00% |